Position in VTRS
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$1,811,987
+$244,314 QoQ
Shares Held
114,105
-1.7% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#263
of 1,016 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VTRS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026State of Alaska, Department of Revenue holds $35,084,807 across 29 Drug Manufacturers - Specialty & Generic names. VTRS ranks #5 (5.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
18,264 | $9,895,982 | |
| 2 | ALKS |
Alkermes plc.
|
63,841 | $3,344,948 | |
| 3 | ZTS |
Zoetis Inc.
|
41,077 | $2,951,793 | |
| 4 | LQDA |
Liquidia Corp
|
23,136 | $1,844,633 | |
| 5 | VTRS |
Viatris Inc
This page
|
114,105 | $1,811,987 | |
| 6 | NBIX |
Neurocrine Biosciences Inc
|
9,852 | $1,660,456 | |
| 7 | INDV |
Indivior Pharmaceuticals, Inc.
|
40,151 | $1,647,395 | |
| 8 | SUPN |
Supernus Pharmaceuticals, Inc.
|
32,585 | $1,515,527 |
All Filings in VTRS
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,811,987 | 114,105 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $1,567,673 | 116,038 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $1,427,741 | 114,678 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $1,236,985 | 124,948 | Shares | Sole | 2025-10-24 | |
| 2025-06-30 | $1,180,903 | 132,240 | Shares | Sole | 2025-07-16 | |
| 2025-03-31 | $1,216,961 | 139,720 | Shares | Sole | 2025-04-21 | |
| 2024-12-31 | $1,694,196 | 136,080 | Shares | Sole | 2025-01-27 | |
| 2024-09-30 | $2,816,690 | 242,609 | Shares | Sole | 2024-10-24 | |
| 2024-06-30 | $3,783,578 | 355,934 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $2,951,555 | 247,199 | Shares | Sole | 2024-04-19 | |
| 2023-12-31 | $3,091,304 | 285,439 | Shares | Sole | 2024-01-19 | |
| 2023-09-30 | $2,885,666 | 292,664 | Shares | Sole | 2023-10-16 | |
| 2023-06-30 | $2,964,598 | 297,054 | Shares | Sole | 2023-07-25 | |
| 2023-03-31 | $3,846,778 | 399,873 | Shares | Sole | 2023-04-17 | |
| 2022-12-31 | $4,536,120 | 407,558 | Shares | Sole | 2023-01-12 | |
| 2022-09-30 | $3,556,571 | 417,438 | Shares | Sole | 2022-10-20 | |
| 2022-06-30 | $4,785,449 | 457,063 | Shares | Sole | 2022-07-08 | |
| 2022-03-31 | $4,435,209 | 407,648 | Shares | Sole | 2022-04-14 | |
| 2021-12-31 | $5,892,896 | 435,543 | Shares | Sole | 2022-01-12 | |
| 2021-09-30 | $6,400,179 | 472,338 | Shares | Sole | 2021-10-07 | |
| 2021-06-30 | $6,833,963 | 478,234 | Shares | Sole | 2021-07-12 | |
| 2021-03-31 | $7,483,491 | 535,683 | Shares | Sole | 2021-04-09 | |
| 2020-12-31 | $10,122,204 | 540,139 | Shares | Sole | 2021-01-08 | |
| No filing history on record for this holder in this stock. | ||||||